
Effect of Matrix Metalloproteinase Inhibition on Pancreatic Cancer Invasion and Metastasis
Author(s) -
Ramon E. Jimenez,
Werner Hartwig,
Bozena Antoniu,
Carolyn C. Compton,
Andrew L. Warshaw,
Carlos Fernándezdel Castillo
Publication year - 2000
Publication title -
annals of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.153
H-Index - 309
eISSN - 1528-1140
pISSN - 0003-4932
DOI - 10.1097/00000658-200005000-00004
Subject(s) - medicine , pancreatic cancer , mmp2 , mmp9 , metastasis , in vivo , zymography , matrix metalloproteinase , apoptosis , cancer research , viability assay , cancer , cancer cell , matrix metalloproteinase inhibitor , gentamicin protection assay , pathology , biology , downregulation and upregulation , biochemistry , microbiology and biotechnology , gene
To investigate the effect of a matrix metalloproteinase (MMP) inhibitor, BB-94, on the viability, invasion, and metastases of pancreatic cancer.